Menu
Log in
  • Home
  • IDAC 37th Annual Southern California Spring Symposium

IDAC 37th Annual Southern California Spring Symposium

  • May 06, 2023
  • 7:30 AM
  • May 07, 2023
  • 1:00 PM
  • Huntington Beach Hyatt Regency

Registration


Registration is closed

IDAC 37th Annual Spring Symposium May 6 – 7, 2023

Huntington Beach Hyatt Regency

Saturday, May 6

0730 – 0830: Check-in, Breakfast Buffett - Industry exhibit visits

0830-0840 – Opening Remarks – Dr. James McKinnell, President, IDAC

0840 – 0940 - Top 10 Literature updates –Christopher Graber, MD MPH, FIDSA, is a Professor of Clinical Medicine at the David Geffen School of Medicine at UCLA and a faculty member of the Infectious Diseases Section at the VA Greater Los Angeles Healthcare System. 

0940 – 1000 - Morning Break, Vendor Visits

1000 – 1100 - Screening and Prophylaxis of Infectious Diseases in Solid Organ Transplantation – Ashrit Multani, MBBS, Assistant Clinical Professor, David Geffen School of Medicine at UCLA.

1100-1200 - HIV Update: Long Term Injectables – Eric Daar, MD, Chief, Division of HIV Medicine, Harbor-UCLA Medical Center; Investigator, Lundquist Institute; Professor of Medicine, David Geffen School of Medicine

1200 – 1315 - Lunch, Vendor Visits,

12:30 - Breakout Sessions

1315 – 1415 – Nontuberculous Mycobacterial Infections – Charles Daley, MD, Chief, Division of Mycobacterial and Respiratory Infections, Department of Medicine, National Jewish Health

1415 – 1430 - Afternoon Break, Industry exhibit visits

1430 – 1530 – Malpractice Risks for Infectious Disease Specialists - Kathleen Stillwell, RN, MPA, MHSA, CPHRM, Senior Patient Safety Risk Manager, The Doctors Company / Richard Cahill, Esq., Vice President, Associate General Counsel, The Doctors Company

1530 – 1630 - Immune Suppression and Monoclonals, Impact – Dr. Randy Taplitz, MD, FIDSA, Professor and Chair, Department of Medicine, City of Hope National Medical Center

Sunday, May 7

0730 – 0830 -   Breakfast Buffett, Industry exhibit visits

0830-0840 – Welcome - Dr. James McKinnell, President, IDAC

0840 – 0940 - C auris update – Zachary Rubin, MD, MPH, Chief Healthcare Outreach Unit, Acute Communicable Disease Control Program, Los Angeles County, Department of Public Health

0940 – 1000 – Break, Industry exhibit visits

1000 – 1100 – Antifungal/Molds and Azole Resistance John R. Perfect, MD, James B. Duke Professor of Medicine; Chief, Division of Infectious Diseases and International Health, Duke University Medical Center

1100-1200 - Speed Dating - New Antimicrobials - Ellie J.C. Goldstein, M.D. David Geffen School of Medicine at UCLA Director, R.M. Alden Research Laboratory Santa Monica, CA / David Ha, Pharm.D. ASP/Infectious Diseases Pharmacist, Stanford Medicine Stanford, CA / Ravina Kullar, PharmD, MPH, FIDSA, Expert Stewardship, Inc., Infectious Disease Pharmacist and Researcher

1200 – Symposium Ends

ACCREDITATION--
The Infectious Disease Association of California (IDAC) is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians. IDAC takes responsibility for the content, quality, and scientific integrity of this CME activity.

PHYSICIANS: IDAC designates this educational activity for a maximum of 6.0* AMA PRA Category 1 Credit(s)™ and American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program points for medical knowledge. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.

PHARMACISTS: The California Board of Pharmacy accepts coursework which meets the standard of relevance to pharmacy practice and has been approved for AMA PRA Category 1 Credit™. A maximum of 6.0* C.E.U.s may be reported.

NURSES: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1. Credits™. A maximum of 6.0* C.E.U.s may be reported. .



Powered by Wild Apricot Membership Software